Subject matter expert consultant for drug metabolism pharmacokinetics [dmpk].
Ended Purchase Order Awarded Last action
- Contract number
- 75N95022P00350
- Awardee
-
Pearson Pharma Partners UEI TJN3M3UNJF15
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $330,000
Award facts
- Opportunity
-
- NIHNINDS75N95022Q002 Solicitation number
- Contract value 62% obligated
-
- $330,000.00 Current, with exercised options
- $531,600.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 9 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- Thousand Oaks, CA 91362, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $44,000 | |
| Exercise an Option | $33,000 | |
| Exercise an Option | $39,600 | |
| Exercise an Option | $26,400 | |
| Exercise an Option | $61,600 | |
| Exercise an Option | $13,200 | |
| Exercise an Option | $72,600 | |
| Exercise an Option | $13,200 | |
| Funding Only Action | $13,200 | |
| Original award | $13,200 |
About this award
This is a $531,600.00 Purchase Order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pearson Pharma Partners, a for-profit S Corporation. The contract is for a Subject Matter Expert Consultant to provide services related to Drug Metabolism Pharmacokinetics (DMPK) and has a period of performance through June 30, 2025. The contract was awarded on a labor hours pricing basis and does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95022P00350?
75N95022P00350 was awarded to Pearson Pharma Partners by National Institute on Drug Abuse (National Institutes of Health) on June 30, 2022.
How much is contract 75N95022P00350 worth?
The government has obligated $330,000 on 75N95022P00350. Its potential value, with all options, is $531,600.
Which agency awarded contract 75N95022P00350?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022P00350, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95022P00350 competed?
The extent of competition for 75N95022P00350 was competed under sap. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award